HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Summary of the multidisciplinary guideline 'Varicella'].

Abstract
The multidisciplinary guideline 'Varicella' provides guidelines for diagnosis, therapy, and prevention of chickenpox. At the first pregnancy check, patients should be questioned about previous chickenpox; in case of a negative or doubtful history varicella zoster virus (VZV) serology is indicated. VZV antibody determination is also indicated in patients considered for immunosuppressive therapy and for healthcare workers with a negative VZV history who are in contact with immunocompromised patients. Administration of VZV immunoglobulin within 96 hours following VZV contact can mitigate the infection in pregnant women and patients with T-cell deficiency. VZV immunoglobulin treatment should be considered for newborn infants of mothers who developed chickenpox in the period from five days before to two days after delivery. Antivirals can reduce the severity of infection and are safe during pregnancy. Varicella vaccine protects against chickenpox, but is contraindicated in immunocompromised patients and pregnant women.
AuthorsPh H Flip Rothbarth, Nico G Hartwig, Wim Opstelten
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 155 Issue 51 Pg. A3511 ( 2011) ISSN: 1876-8784 [Electronic] Netherlands
Vernacular TitleSamenvatting van de multidisciplinaire richtlijn 'Varicella'.
PMID22200141 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Viral
  • Antiviral Agents
  • Chickenpox Vaccine
Topics
  • Antibodies, Viral (blood)
  • Antiviral Agents (therapeutic use)
  • Chickenpox (diagnosis, prevention & control, therapy)
  • Chickenpox Vaccine (administration & dosage)
  • Child
  • Child, Preschool
  • Contraindications
  • Female
  • Herpesvirus 3, Human (immunology)
  • Humans
  • Male
  • Netherlands
  • Pregnancy
  • Pregnancy Complications, Infectious (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: